|
HS Code |
149418 |
| Chemical Name | 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid |
| Molecular Formula | C16H10BrNO2 |
| Molecular Weight | 344.16 g/mol |
| Cas Number | 944904-55-6 |
| Appearance | Off-white to light yellow powder |
| Purity | Typically ≥98% |
| Solubility | Slightly soluble in DMSO, insoluble in water |
| Storage Conditions | Store at 2-8°C, away from light and moisture |
| Smiles | C1=CC=C(C=C1)N2C=CC=C(C3=CC=CC=C32)C(=O)OBr |
| Inchi | InChI=1S/C16H10BrNO2/c17-13-8-9-15-12(10-13)14(11-6-2-1-3-7-11)18-7-4-5-10(15)16(19)20/h1-9H,(H,19,20) |
| Logp | Estimated 4.2 |
As an accredited 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle labeled **“6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid, 5g”**, sealed, with hazard pictograms and safety information. |
| Shipping | The chemical **6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid** is securely packaged in compliance with international shipping regulations for hazardous materials. It is shipped in sealed containers, protected against moisture and light, with appropriate labeling and documentation to ensure safe transit and delivery to laboratory or industrial destinations. |
| Storage | 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from direct sunlight and incompatible substances such as strong oxidizers. Keep at room temperature or as recommended by the manufacturer. Minimize exposure to moisture and handle using appropriate personal protective equipment to avoid inhalation or skin contact. |
Applications of 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid in Industrial ManufacturingAs a manufacturer specializing in advanced quinoline derivatives, we supply 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid to several distinguished downstream sectors, each with unique compliance, formulation, and process integration needs. The following segments represent the principal industrial fields realizing repeatable, real-world applications with this material. 1. Pharmaceutical Intermediate for Antitumor Drug SynthesisThe pharmaceutical sector frequently employs this compound as a key intermediate in the multi-stage synthesis of targeted oncology agents within the quinoline family. Pharmaceutical manufacturers rely on its unique molecular scaffold for constructing active pharmaceutical ingredients (APIs) pursuing kinase inhibition therapeutic pathways. The integration starts early in the synthesis route and influences the selectivity and potency of downstream compounds. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate for Systemic Fungicide SynthesisIn crop protection chemistry, multinational and regional agrochemical formulators use this compound for constructing quinoline-based active ingredients incorporated in advanced systemic fungicides. It enters the synthesis route during nitrogen heterocycle assembly, contributing to bioactivity against resistant plant pathogens in cereals and cash crops. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for OLED and Functional Dye SynthesisElectronic materials manufacturers utilize this molecule as a halogen-functionalized precursor in the synthesis of quinoline-based fluorescent dyes and organic light-emitting diode (OLED) emitter layers. Its integration allows tunable emission profiles and improved device stability in advanced optoelectronic applications, particularly in displays and specialty lighting sectors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Fine Chemical R&D and Specialty Compound LibrariesContract research organizations (CROs) and corporate R&D centers adopt this compound as a building block for constructing proprietary quinoline analog libraries. Its halogen and carboxyl functionalities facilitate rapid derivatization, accelerating SAR (structure–activity relationship) programs in medicinal, agricultural, and material science discovery projects. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Over years of working on quinoline derivatives, 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid has steadily secured its place as a go-to building block across diverse research and industrial projects. From sourcing raw materials to refining each batch, every production run tells the same story: attention to detail means fewer headaches for scientists down the line. We don’t cut corners with purification or final isolation. Because we handle synthesis from the ground up, there’s never a doubt about trace contamination or batch-to-batch variability—an issue that often trips up buyers getting something secondhand or from an unstable supply chain.
The process itself can be unforgiving, especially at the bromination step, but over time we've learned how key reaction conditions steer the product toward minimal by-products and consistently sharp melting points. Far from a bulk commodity, this molecule rewards craftsmanship in how it is handled, washed, and dried. Every jar that leaves our plant reflects that hard-won expertise.
Chemists working in medicinal chemistry, material science, and advanced agrochemical research often look for a scaffold that can open doors to a wider set of analogues in structure-activity-relationship studies. 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid finds frequent use because its quinoline core and carboxylic handle make linker chemistry straightforward. The presence of a bromine at the 6-position gives it a reactivity profile that enables Suzuki and Sonogashira-type cross-coupling, allowing custom-tailored molecules from one starting point without reworking half the route each time.
We see customers using this product for late-stage diversification—attaching different functional groups not just to the phenyl ring but right at the bromo position. This avoids revisiting earlier synthetic steps, so medicinal chemists push through more structural variants per month. The carboxyl functional group lets downstream amide coupling go smoothly, which is valuable for anyone keen to explore novel amides or bioconjugates.
Running a chemical factory means you never ignore small changes. Any blip in color during workup or faint impurity caught by HPLC can quickly cost weeks downstream, either in wasted time or inconclusive analytical results for our customers. We run infrared and NMR checks on every batch, using in-house standards rather than relying on public spectra. Consistency is everything for researchers—they shouldn’t lose time troubleshooting a reaction because of a missing methyl group, a trace metal, or extra moisture. Lab-scale research and scale-up runs both demand knowing that at ten grams or ten kilograms, the product profile is the same.
Our records go back years, letting us trace raw material batches, operator logs, or unusual test results. Frequent audits help us catch not only technical errors but also problems with packaging or labeling that might disrupt customer workflows. It might take longer on our end to run these tests and track each drum or jar so closely, but seeing repeat researchers return confirms the value of transparency.
Molecular structure plays out in tangible ways during synthesis. Many quinoline-based building blocks are substituted at less reactive positions or lack the balance between functional groups seen here. Take the 6-bromo group—it activates the ring toward palladium-catalyzed substitutions while holding up to hydrolysis. The 4-carboxylic placement, far from being just a synthetic handle, resists decarboxylation through most standard protocol stresses. Pick a molecule with the substitution pattern off by one or two carbons, and the whole route to certain analogues falls flat or gives dismal yields.
Other manufacturers sometimes offer the ethyl ester version or unhalogenated analogues. These lack the same versatility in cross-coupling strategies or show different solubility in polar solvents, affecting purification steps. Through our process, the 6-bromo product shows a clear TLC spot in typical dichloromethane-methanol systems and doesn’t drag along multiple polymorphs—making large-scale chromatography easier to plan and execute.
It’s common knowledge, but often neglected, that differences in batch handling—residual solvent, pH drift, or particle sizing—matter enormously for downstream chemistry. What gets written off by some as a small quality issue impacts reactivity and reproducibility tremendously. We calibrate particle fineness to improve suspension in standard polar aprotic solvents without creating needless dust during transfer. This subtle shift echoes through any automated or manual dosing operation, sidestepping jammed augers or inhomogeneous dissolutions in microplate-format screening.
Many researchers initially buy small quantities from global distributors, only to struggle with scale-up when their source shifts unexpectedly or documentation lacks rigor. Since we’ve had direct partnerships with industrial and academic chemists, our manufacturing records stay accessible, and questions about physical parameters or scale transitions never leave a buyer stranded. Beyond just handing over a package and a COA sheet, we stay in touch on technical issues, giving feedback from both our internal application tests and the shared experiences of others using the product.
Through years of interaction, some projects move from milligrams in the lab to pilot lots in applied settings—catalysis development, advanced pigment work, and small-molecule therapy optimization. We track these results whenever possible and feed that back into process tweaks or upgraded packaging choices. Fewer packaging breakages, moisture ingress incidents, or long lead times mean fewer headaches for researchers on tight budgets or critical development timelines.
We never publish theoretical purity levels or ignore common contaminants that slip undetected through basic chromatography. Every specification emerges from dialog with actual users—and field data showing not just elemental purity, but typical reaction side products that can matter at single-digit ppm. Knowing that most end-users plan reductive coupling or amide bond formation, we minimize heavy metals and keep chloride to a minimum—sidestepping unexpected catalyst poisoning at bench or kilo scale.
Physical stability, not just chemical, governs how 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid performs over long storage. Our team inspects each lot for dynamic slumping or hard-to-break lumps due to subtle shifts in micro-moisture, which can be a major pitfall when working with carboxylic acids. We favor glass over plastic linings for longer-term stability. These choices respond to lessons learned from actual product returns or crystallization failures reported from labs worldwide.
Demands on starting materials have never been higher. Computational methods generate a near-limitless array of target molecules, driving research teams to probe more chemical space with less time and expense. Because of its flexible reactivity and robust baseline properties, 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid gets called on for hit-to-lead evolution in pharmaceutical pipelines, and in functional material design aiming for novel photophysical traits.
We try to anticipate process shifts, offering advice on handling for applications that push beyond typical drug synthesis. For example, rare electronics applications or photochemistry studies need residue-free materials at slightly different particle sizes or crystalline forms than standard practice. We react to those demands by redesigning drying steps or mill configurations—rather than shipping a one-size-fits-all batch and hoping users adapt.
Supplying customers at scale invariably brings up tough questions about stability under various conditions, compatibility with strange new catalysts, or performance in automated reagent feeders. No web listing or data sheet tells the whole story. We don’t hesitate to share long-term dissolution or storage data when buyers ask, even if some details show a less-than-perfect story. For instance, a few years back, a polymer functionalization lab flagged difficulty in keeping the acid in solution above 40°C and received not just documentation, but advice on storing and shipping under dry argon—a practice we’ve since routinely offered for customers in similar climates.
We also believe in showing problems transparently. If certain catalyst traces can sometimes carry through the process, we flag it early and offer analytical data up front. We have adjusted filtering protocols midstream if metal contamination threatens certain downstream transformations; this responsiveness is part of our ongoing dialog with actual bench chemists.
Specialty chemicals don’t sit on supermarket shelves; their true value emerges only after months or years of experimental work. Each kilo or drum of 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid navigates regulations, documentation, shipping stresses, and environmental concerns. It’s not enough to meet regulatory minimums or quote generic standards—we test packaging to withstand realistic warehouse, customs, and lab conditions. Changing customs regimes, environmental rules, or waste stream constraints around the world have directly shaped our own labeling, documentation, and shipping practices.
Clients rely on us to demystify potential environmental or safety hurdles before they derail a project. By staying updated on hazardous materials rules and sustainability programs in each region, we can proactively suggest compliant packaging or updated documentation before a shipment faces a customs holdup—saving researchers weeks of lost time and missed grant deadlines.
We see the challenge isn’t just making or selling more product, but actually raising standards for what counts as “research-grade.” By focusing investment on analytical infrastructure and staff training, we ensure that 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid doesn’t just meet a basic spec but outperforms others in real-world reactions. This approach means higher up-front investment in monitoring and process control, but produces a stronger, more credible supply chain. Research teams around the world have already reported better consistency in key transition-metal-catalyzed reactions and fewer setbacks in formulation when using our material.
Quality in specialty chemicals often escapes formal, quantitative rating—but every failed experiment or delayed scale-up serves as a clear sign that something upstream could have been managed better. We welcome tough scrutiny, whether from contract research organizations, university screening centers, or industrial QC labs. Lessons learned guide each improvement in how we work—from small tweaks in particle sizing, to broader efforts in green chemistry, to cross-team training between production and QA staff.
Selling chemicals isn’t just about moving jars or drums off the shelf. Our long view is grounded in forming partnerships with research teams, delivering not only a reliable supply of 6-Bromo-2-Phenyl-Quinoline-4-Carboxylic Acid but also shared expertise in how to maximize each batch’s value. Whether troubleshooting a tricky synthetic coupling, adjusting for special handling, or exploring scale-up for a new application, we back up every shipment with full documentation, analytical support, and lessons learned from the field. In a landscape crowded with fleeting offers and shifting suppliers, we hold ourselves accountable for every molecule—so the world’s leading innovators can stay focused on discovery, not supply-chain uncertainty.